A Phase 1 clinical trials studying multiple-ascending dose of STM-01 in patients with heart failure.
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs STM 01 (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 24 Jan 2025 New trial record
- 22 Jan 2025 According to Secretome Therapeutics media release, company expects to begin this trial in the first quarter of 2025.